WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT
Patients with liver disease are more prone to thrombosis and bleeding events than healthy people.
The decision to use anticoagulation in patients with pulmonary embolism and liver disease requires a cautious evaluation of the risks of bleeding and the benefits of anticoagulation.